Septic shock and the use of norepinephrine in an intermediate care unit: Mortality and adverse events

• Mikael Hallengren ,

  * E-mail: mikael.hallengren@sll.se

  Affiliation Department of Clinical Sciences, Division of Anaesthesia and Intensive Care, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden

  http://orcid.org/0000-0002-1481-8511

  ⨯
• Per Åstrand,

  Affiliation Department of Clinical Sciences. Division of Internal Medicine, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden

  ⨯
• Staffan Eksborg,

  Affiliation Department of Women's and Children's Health, Childhood Cancer Research Unit Q6:05 Karolinska Institutet, Astrid Lindgren Children's Hospital, Karolinska University Hospital Solna, Stockholm, Sweden

  ⨯
• Hans Barle,

  Affiliation Department of Clinical Sciences, Division of Anaesthesia and Intensive Care, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden

  ⨯
• Claes Frostell

  Affiliations Department of Clinical Sciences, Division of Anaesthesia and Intensive Care, Karolinska Institutet, Danderyd Hospital, Stockholm, Sweden, Claes Frostell Research and Consulting AB, Stockholm, Sweden

  ⨯